These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22985748)

  • 1. Towards a structural understanding of PARP1 activation and related signalling ADP-ribosyl-transferases.
    Hassler M; Ladurner AG
    Curr Opin Struct Biol; 2012 Dec; 22(6):721-9. PubMed ID: 22985748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a unified nomenclature for mammalian ADP-ribosyltransferases.
    Hottiger MO; Hassa PO; Lüscher B; Schüler H; Koch-Nolte F
    Trends Biochem Sci; 2010 Apr; 35(4):208-19. PubMed ID: 20106667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structure of ADP-ribosylating enzyme and DNA repair].
    Uchida K
    Nihon Rinsho; 1993 Nov; 51(11):3051-61. PubMed ID: 8277589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the enzymatic catalysis of poly(ADP-ribose) polymerase by dsDNA, polyamines, Mg2+, Ca2+, histones H1 and H3, and ATP.
    Kun E; Kirsten E; Mendeleyev J; Ordahl CP
    Biochemistry; 2004 Jan; 43(1):210-6. PubMed ID: 14705947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin architecture and functions: the role(s) of poly(ADP-RIBOSE) polymerase and poly(ADPribosyl)ation of nuclear proteins.
    Faraone-Mennella MR
    Biochem Cell Biol; 2005 Jun; 83(3):396-404. PubMed ID: 15959565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of mono(ADP-ribosyl)ated poly(ADP-ribose) polymerase.
    Mendoza-Alvarez H; Alvarez-Gonzalez R
    Biochemistry; 1999 Mar; 38(13):3948-53. PubMed ID: 10194306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex roles of members of the ADP-ribosyl transferase super family in immune defences: looking beyond PARP1.
    Welsby I; Hutin D; Leo O
    Biochem Pharmacol; 2012 Jul; 84(1):11-20. PubMed ID: 22402301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the mammalian ADP-ribosyl-transferases clostridia toxin-like (ARTCs) family.
    Di Girolamo M; Fabrizio G
    Biochem Pharmacol; 2019 Sep; 167():86-96. PubMed ID: 31283932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARPs and the DNA damage response.
    Sousa FG; Matuo R; Soares DG; Escargueil AE; Henriques JA; Larsen AK; Saffi J
    Carcinogenesis; 2012 Aug; 33(8):1433-40. PubMed ID: 22431722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SnapShot: ADP-Ribosylation Signaling.
    Hottiger MO
    Mol Cell; 2015 Jun; 58(6):1134-1134.e1. PubMed ID: 26091348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity-based assay for human mono-ADP-ribosyltransferases ARTD7/PARP15 and ARTD10/PARP10 aimed at screening and profiling inhibitors.
    Venkannagari H; Fallarero A; Feijs KL; Lüscher B; Lehtiö L
    Eur J Pharm Sci; 2013 May; 49(2):148-56. PubMed ID: 23485441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation.
    Kleine H; Poreba E; Lesniewicz K; Hassa PO; Hottiger MO; Litchfield DW; Shilton BH; Lüscher B
    Mol Cell; 2008 Oct; 32(1):57-69. PubMed ID: 18851833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribosyl)ation, PARP, and aging.
    Beneke S; Bürkle A
    Sci Aging Knowledge Environ; 2004 Dec; 2004(49):re9. PubMed ID: 15590998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and outlook in studying the substrate specificities of PARPs and related enzymes.
    Suskiewicz MJ; Palazzo L; Hughes R; Ahel I
    FEBS J; 2021 Apr; 288(7):2131-2142. PubMed ID: 32785980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs.
    Carter-O'Connell I; Cohen MS
    Curr Protoc Chem Biol; 2015 Jun; 7(2):121-39. PubMed ID: 26344237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARPing for balance in the homeostasis of poly(ADP-ribosyl)ation.
    Schuhwerk H; Atteya R; Siniuk K; Wang ZQ
    Semin Cell Dev Biol; 2017 Mar; 63():81-91. PubMed ID: 27664469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications.
    Xu S; Bai P; Little PJ; Liu P
    Med Res Rev; 2014 May; 34(3):644-75. PubMed ID: 24002940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-Ribose) Polymerase 1: Cellular Pluripotency, Reprogramming, and Tumorogenesis.
    Jiang BH; Tseng WL; Li HY; Wang ML; Chang YL; Sung YJ; Chiou SH
    Int J Mol Sci; 2015 Jul; 16(7):15531-45. PubMed ID: 26184161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.
    Ke Y; Wang C; Zhang J; Zhong X; Wang R; Zeng X; Ba X
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism.
    Davidovic L; Vodenicharov M; Affar EB; Poirier GG
    Exp Cell Res; 2001 Aug; 268(1):7-13. PubMed ID: 11461113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.